An NPR report explores how some patients are turning to the gray market to buy raw ingredients for obesity medications as a cheaper alternative to prescription drugs. AACE President Scott D. Isaacs, MD, FACP, FACE, warns about the risks of getting contaminated or counterfeit products, including infections, dosing errors, and lack of effectiveness.